These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 27763257)
1. Mycobacterium bovis BCG and New Vaccines for the Prevention of Tuberculosis. Lahey T; von Reyn CF Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763257 [TBL] [Abstract][Full Text] [Related]
2. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice. Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310 [TBL] [Abstract][Full Text] [Related]
3. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis. Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011 [TBL] [Abstract][Full Text] [Related]
4. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection. Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555 [TBL] [Abstract][Full Text] [Related]
5. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis. Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524 [TBL] [Abstract][Full Text] [Related]
6. Heterologous Boost Following Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X Front Immunol; 2018; 9():2439. PubMed ID: 30425711 [TBL] [Abstract][Full Text] [Related]
7. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection. Mollenkopf HJ; Kursar M; Kaufmann SH J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936 [TBL] [Abstract][Full Text] [Related]
8. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? Moliva JI; Turner J; Torrelles JB Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069 [TBL] [Abstract][Full Text] [Related]
9. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design. Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM Front Immunol; 2019; 10():2806. PubMed ID: 31849980 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection. Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942 [TBL] [Abstract][Full Text] [Related]
11. BCG - old workhorse, new skills. Gengenbacher M; Nieuwenhuizen NE; Kaufmann S Curr Opin Immunol; 2017 Aug; 47():8-16. PubMed ID: 28719821 [TBL] [Abstract][Full Text] [Related]
12. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin. Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102 [TBL] [Abstract][Full Text] [Related]
13. Recombinant BCG as a vaccine vehicle to protect against tuberculosis. Triccas JA Bioeng Bugs; 2010; 1(2):110-5. PubMed ID: 21326936 [TBL] [Abstract][Full Text] [Related]
14. Post-exposure vaccination with the vaccine candidate Bacillus Calmette-Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis. Gengenbacher M; Kaiser P; Schuerer S; Lazar D; Kaufmann SH Microbes Infect; 2016 May; 18(5):364-8. PubMed ID: 26994939 [TBL] [Abstract][Full Text] [Related]
15. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis. Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884 [TBL] [Abstract][Full Text] [Related]
16. Persistence of Mycobacterium bovis bacillus Calmette-Guérin (BCG) Danish in white-tailed deer (Odocoileus virginianus) vaccinated with a lipid-formulated oral vaccine. Palmer MV; Thacker TC; Waters WR; Robbe-Austerman S; Aldwell FE Transbound Emerg Dis; 2014 Jun; 61(3):266-72. PubMed ID: 23173832 [TBL] [Abstract][Full Text] [Related]
17. Experimental models used in evaluating anti-tuberculosis vaccines: the latest advances in the field. Mantilla Galindo A; Ocampo M; Patarroyo MA Expert Rev Vaccines; 2019 Apr; 18(4):365-377. PubMed ID: 30773949 [TBL] [Abstract][Full Text] [Related]
18. Animal models of protective immunity in tuberculosis to evaluate candidate vaccines. Griffin JF; Mackintosh CG; Buchan GS Trends Microbiol; 1995 Nov; 3(11):418-24. PubMed ID: 8574514 [TBL] [Abstract][Full Text] [Related]
20. New vaccines for the prevention of tuberculosis. von Reyn CF; Vuola JM Clin Infect Dis; 2002 Aug; 35(4):465-74. PubMed ID: 12145732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]